Just About Anyone Can Sell You GLP-1s Online Now

In a significant shift, anyone with a website and some capital can now sell GLP-1 weight loss drugs online, thanks to the proliferation of turnkey telehealth services. This trend, driven by companies like JustAnswer and others, has expanded access to prescription medications but also raises questions about safety, regulation, and quality control.

Recent reports indicate that companies such as JustAnswer, WhiteLabelMD, Fuse Health, and others are offering ready-made telehealth infrastructure that connects patients with clinicians for prescriptions of drugs like semaglutide and tirzepatide. These platforms often operate with limited oversight, relying on third-party providers to handle customer service, compliance, and prescribing processes.

Industry insiders like Jiten Chhabra of CareValidate note that the industry is experiencing an increase in new virtual clinics launching—sometimes one per day—many of which target treatments like GLP-1s, peptides, and hormone therapies. Some of these companies are run by individuals without healthcare backgrounds, including influencers, entrepreneurs, and marketing firms.

Notable cases include Medvi, which reportedly reached over $400 million in sales in 2025 without directly employing healthcare professionals, and GoodGirlRX, founded by reality TV star Savannah Chrisley, which has faced FDA warnings and lawsuits over advertising claims. The FDA has recently issued warnings to some clinics regarding false advertising and unsubstantiated claims.

Implications of Widespread GLP-1 Sales Online

This trend could have implications for public health, as medications like GLP-1s are potent drugs that require appropriate medical oversight. The increased accessibility may lead to issues related to misuse, incorrect dosing, and prescribing by unqualified individuals. Additionally, the lack of regulation raises concerns about potential fraud, misleading marketing, and the quality of care provided.

For consumers, the proliferation of these services can make it challenging to identify reputable providers. The entry of non-healthcare entities into this market also raises questions about accountability and safety standards.

Rapid Growth of Virtual Clinics and Regulatory Challenges

The telehealth industry has expanded significantly over the past two years, facilitated by turnkey platforms that lower barriers to entry. Companies like CareValidate and Fuse Health provide infrastructure that allows individuals to establish virtual clinics quickly. This growth has been driven by increasing demand for online health services, especially for weight loss and aesthetic treatments.

However, this expansion occurs in a regulatory environment with limited oversight; the FDA does not require registration for these clinics, and enforcement actions are inconsistent. Past incidents, such as Medvi and GoodGirlRX, illustrate potential risks associated with unverified claims and insufficient oversight. Experts warn that the current environment could lead to misuse and potential harm, especially as non-medical entrepreneurs enter the space.

“Anybody can now get into telehealth because of infrastructure companies like ours. We’re in an era of telehealth for everything.”

— Jiten Chhabra, chief medical officer of CareValidate

Extent and Regulation of the Growing Market

The number of companies operating in this space is not well documented, as the FDA does not require registration, and many startups remain untracked. As a result, understanding the full scope of online GLP-1 sales and the quality standards across providers remains challenging, raising questions about overall safety and regulatory oversight.

Regulatory Crackdowns and Industry Responses Expected

Regulatory agencies such as the FDA are expected to increase oversight efforts, potentially issuing more warning letters and enforcement actions against unqualified clinics. Industry groups and established companies may also advocate for clearer regulations to better protect consumers. Consumers are advised to exercise caution and verify the credentials of healthcare providers when seeking prescription medications online.

Key Questions

Can I legally buy GLP-1 drugs online?

GLP-1 drugs require a prescription and should be obtained through licensed healthcare providers. Many online sources operate without proper regulation, which can pose risks.

What are the risks of buying GLP-1s from unverified sources?

Risks include incorrect dosing, counterfeit or contaminated products, and lack of medical supervision, which can lead to adverse health effects.

How can consumers identify reputable telehealth providers?

Consumers should look for providers with proper licensing, verified medical staff, and clear compliance with regulations. Certifications from organizations like LegitScript can help verify legitimacy.

Will regulation prevent these online sales?

Regulatory agencies are increasing enforcement efforts, but the rapid growth of the market presents ongoing challenges. Consumers should remain cautious and seek verified providers.

Source: WIRED